Advanced Biomed (ADVB) said Thursday it priced its initial public offering of 1.6 million shares at $4 per share, for expected gross proceeds of about $6.6 million.
The shares have been approved for listing on Nasdaq and are expected to start trading on Thursday under the ticker "ADVB," the company said.
Underwriters have been given a 45-day option to buy up to an additional 246,000 shares, Advanced Biomed said.
The offering is expected to close on or about Friday, it said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.